Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Rechallenge with lamotrigine after initial rash

S J Tavernor1, I C Wong, R Newton

  • 1David Lewis Centre, Warford, Nr Alderley Edge, Cheshire, UK.

Seizure
|March 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Paediatric non-theatre emergency airway management.

Anaesthesia·2023
Same author

HIV sero-positivity and risk factors for ischaemic and haemorrhagic stroke in hospitalised patients in Uganda: A prospective-case-control study.

Public health in practice (Oxford, England)·2022
Same author

Photon quantum entanglement in the MeV regime and its application in PET imaging.

Nature communications·2021
Same author

Optical and mechanical design of a telescope for lunar spectral irradiance measurements from a high-altitude aircraft.

The Review of scientific instruments·2020
Same author

A ten-year study of Retinoblastoma in Uganda: An approach to improving outcome with limited resources.

Cancer epidemiology·2020
Same author

Variance in interpretation of plain radiographs for the assessment of third molars for coronectomy: our solution.

The British journal of oral & maxillofacial surgery·2018

Lamotrigine rechallenge was successful in most patients who previously experienced a rash. Six out of eight patients tolerated lamotrigine reintroduction without recurrent skin reactions, suggesting potential for cautious re-dosing.

Area of Science:

  • Pharmacology
  • Dermatology
  • Clinical Neurology

Background:

  • Lamotrigine is an anticonvulsant medication used for epilepsy and bipolar disorder.
  • Skin rash is a known adverse effect of lamotrigine, necessitating careful monitoring.
  • Previous rash reactions can complicate future lamotrigine treatment decisions.

Observation:

  • Eight patients with a history of lamotrigine-induced rash were rechallenged with the medication.
  • Six patients tolerated lamotrigine reintroduction without any recurrence of rash.
  • Two patients experienced different or dose-related rash recurrences upon rechallenge.

Findings:

  • The majority of patients (75%) tolerated lamotrigine rechallenge without adverse dermatological events.
  • One patient experienced a mild, different rash, while another had a dose-dependent reaction.

Related Experiment Videos

  • Successful re-dosing was observed even after initial dose-related rash in one case with dose adjustments.

    • Implications:

    • Patients with a prior lamotrigine rash and good therapeutic response may be candidates for cautious re-dosing.
    • Careful dose titration and monitoring are crucial when reconsidering lamotrigine after a rash.
    • This study supports individualized treatment strategies for lamotrigine-induced hypersensitivity reactions.